DDrare
Disease
Drug
Target Gene/Pathway
問合せ先
EN
Drug
Description in Trials
/
DrugBank
/
KEGG DRUG
Search
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
Other
Search results
10
50
100
ALL
descriptions per page:
Showing 1 to 10 of 43 descriptions
Filter by
Reset
|
No.
薬物名（臨床試験情報から抽出）
DrugBank
KEGG DRUG
KEGG GENES
KEGG PATHWAY
指定難病告示番号
1
14C]-RPC1063 Solution (0.1 mg/mL) for Oral
Administration
-
-
-
-
3件:
13
13
,
96
,
97
💬
1. 14C]-RPC1063 Solution (0.1 mg/mL) for Oral
Administration
×
告示番号
日本語名
英語名
13
多発性硬化症／視神経脊髄炎
Multiple sclerosis/Neuromyelitis optica
96
クローン病;回腸末端炎
Crohn disease
97
潰瘍性大腸炎
Ulcerative colitis
2
ADMINISTRATION
-
-
-
-
1件:
19
19
💬
2.
ADMINISTRATION
×
告示番号
日本語名
英語名
19
ライソゾーム病
Lysosomal storage disease
3
Administration
of a high dose of desipramine
1件:
Desipramine
Desipramine
1件:
Desipramine
Desipramine
💬
3.
Administration
of a high dose of desipramine
×
Name
Other Names
Desipramine
Desipramine (INN)
デシプラミン
2件:
SLC6A2
SLC6A2
,
SLC6A4
💬
3.
Administration
of a high dose of desipramine
×
Name
Full Name
SLC6A2
solute carrier family 6 member 2
SLC6A4
solute carrier family 6 member 4
2件:
Serotonergic synapse
Serotonergic synapse
,
Synaptic vesicle cycle
💬
1件:
156
156
💬
3.
Administration
of a high dose of desipramine
×
告示番号
日本語名
英語名
156
レット症候群
Rett syndrome
4
Administration
of a low dose of desipramine
1件:
Desipramine
Desipramine
1件:
Desipramine
Desipramine
💬
4.
Administration
of a low dose of desipramine
×
Name
Other Names
Desipramine
Desipramine (INN)
デシプラミン
2件:
SLC6A2
SLC6A2
,
SLC6A4
💬
4.
Administration
of a low dose of desipramine
×
Name
Full Name
SLC6A2
solute carrier family 6 member 2
SLC6A4
solute carrier family 6 member 4
2件:
Serotonergic synapse
Serotonergic synapse
,
Synaptic vesicle cycle
💬
1件:
156
156
💬
4.
Administration
of a low dose of desipramine
×
告示番号
日本語名
英語名
156
レット症候群
Rett syndrome
5
Administration
of an ACE-inhibitor or not
-
-
-
-
1件:
210
210
💬
5.
Administration
of an ACE-inhibitor or not
×
告示番号
日本語名
英語名
210
単心室症
Single Ventricle
6
Administration
of Cimzia®
1件:
Certolizumab pegol
Certolizumab pegol
1件:
Certolizumab pegol
Certolizumab pegol
💬
6.
Administration
of Cimzia®
×
Name
Other Names
Certolizumab pegol
Certolizumab pegol (USAN/INN)
Certolizumab pegol (genetical recombination) (JAN)
Cimzia (TN)
セルトリズマブペゴル
シムジア
1件:
TNF
TNF
💬
6.
Administration
of Cimzia®
×
Name
Full Name
TNF
tumor necrosis factor
67件:
AGE-RAGE signaling pathway in diabetic complications
AGE-RAGE signaling pathway in diabetic complications
,
Adipocytokine signaling pathway
,
African trypanosomiasis
,
Alcoholic liver disease
,
Allograft rejection
,
Alzheimer disease
,
Amoebiasis
,
Amyotrophic lateral sclerosis
,
Antifolate resistance
,
Antigen processing and presentation
,
Apoptosis
,
Asthma
,
C-type lectin receptor signaling pathway
,
Chagas disease
,
Coronavirus disease - COVID-19
,
Cytokine-cytokine receptor interaction
,
Dilated cardiomyopathy
,
Epstein-Barr virus infection
,
Fc epsilon RI signaling pathway
,
Fluid shear stress and atherosclerosis
,
Graft-versus-host disease
,
Hematopoietic cell lineage
,
Hepatitis B
,
Hepatitis C
,
Herpes simplex virus 1 infection
,
Human T-cell leukemia virus 1 infection
,
Human cytomegalovirus infection
,
Human immunodeficiency virus 1 infection
,
Human papillomavirus infection
,
Hypertrophic cardiomyopathy
,
IL-17 signaling pathway
,
Inflammatory bowel disease
,
Influenza A
,
Insulin resistance
,
Legionellosis
,
Leishmaniasis
,
Lipid and atherosclerosis
,
MAPK signaling pathway
,
Malaria
,
NF-kappa B signaling pathway
,
NOD-like receptor signaling pathway
,
Natural killer cell mediated cytotoxicity
,
Necroptosis
,
Non-alcoholic fatty liver disease
,
Osteoclast differentiation
,
Pathogenic Escherichia coli infection
,
Pathways of neurodegeneration - multiple diseases
,
Pertussis
,
Prion disease
,
Proteoglycans in cancer
,
RIG-I-like receptor signaling pathway
,
Rheumatoid arthritis
,
Salmonella infection
,
Shigellosis
,
Sphingolipid signaling pathway
,
Systemic lupus erythematosus
,
T cell receptor signaling pathway
,
TGF-beta signaling pathway
,
TNF signaling pathway
,
Toll-like receptor signaling pathway
,
Toxoplasmosis
,
Tuberculosis
,
Type I diabetes mellitus
,
Type II diabetes mellitus
,
Viral protein interaction with cytokine and cytokine receptor
,
Yersinia infection
,
mTOR signaling pathway
💬
67件:
AGE-RAGE signaling pathway in diabetic complications
,
Adipocytokine signaling pathway
,
African
...
1件:
46
46
💬
6.
Administration
of Cimzia®
×
告示番号
日本語名
英語名
46
悪性関節リウマチ
Malignant rheumatoid arthritis
7
Administration
of drug (Interferon-gamma 1-b) subcutaneously
-
-
-
-
1件:
65
65
💬
7.
Administration
of drug (Interferon-gamma 1-b) subcutaneously
×
告示番号
日本語名
英語名
65
原発性免疫不全症候群
Primary immunodeficiency
8
Administration
of Methylprednisolone + Prednisone + Mycophenolate mofetil
4件:
Methylprednisolone
Methylprednisolone
,
Mycophenolate mofetil
,
Mycophenolic acid
,
Prednisone
4件:
Methylprednisolone
Methylprednisolone
,
Prednisone
,
Mycophenolate mofetil
,
Mycophenolic acid
💬
8.
Administration
of Methylprednisolone + Prednisone + Mycophenolate mofetil
×
Name
Other Names
Methylprednisolone
Methylprednisolone (JP18/USP/INN)
Medrol (TN)
METHYLPRED DP
メチルプレドニゾロン
メドロール
Prednisone
Prednisone (USP)
Prednisone monohydrate
Deltasone (TN)
Meticorten (TN)
Rayos (TN)
プレドニゾン水和物
Mycophenolate mofetil
Mycophenolate mofetil (JAN/USP)
Cellcept (TN)
ミコフェノール酸モフェチル
セルセプト
ミコフェノール酸
Mycophenolic acid
Mycophenolic acid (USAN/INN)
Mycophenolic acid (TN)
ミコフェノール酸
3件:
IMPDH1
IMPDH1
,
IMPDH2
,
NR3C1
💬
8.
Administration
of Methylprednisolone + Prednisone + Mycophenolate mofetil
×
Name
Full Name
IMPDH1
inosine monophosphate dehydrogenase 1
IMPDH2
inosine monophosphate dehydrogenase 2
NR3C1
nuclear receptor subfamily 3 group C member 1
5件:
Drug metabolism - other enzymes
Drug metabolism - other enzymes
,
Metabolic pathways
,
Neuroactive ligand-receptor interaction
,
Nucleotide metabolism
,
Purine metabolism
💬
5件:
Drug metabolism - other enzymes
,
Metabolic pathways
,
Neuroactive ligand-receptor interaction
,
Nu
...
1件:
49
49
💬
8.
Administration
of Methylprednisolone + Prednisone + Mycophenolate mofetil
×
告示番号
日本語名
英語名
49
全身性エリテマトーデス
Systemic lupus erythematosus
9
Administration
of methylprednisolone, paracetamol and dexchlorpheniramine
3件:
Acetaminophen
Acetaminophen
,
Dexchlorpheniramine
,
Methylprednisolone
3件:
Acetaminophen
Acetaminophen
,
Methylprednisolone
,
Dexchlorpheniramine
💬
9.
Administration
of methylprednisolone, paracetamol and dexchlorpheniramine
×
Name
Other Names
Acetaminophen
Acetaminophen (JP18/USP)
Paracetamol (INN)
Tylenol (TN)
OFIRMEV
GOOD NEIGHBOR PHARMACY PAIN RELIEF
アセトアミノフェン
パラセタモール
アセリオ
アルピニー
アンヒバ
カロナール
ピレチノール
Methylprednisolone
Methylprednisolone (JP18/USP/INN)
Medrol (TN)
METHYLPRED DP
メチルプレドニゾロン
メドロール
Dexchlorpheniramine
Dexchlorpheniramine (INN)
d-Chloropheniramine
Dapriton (TN)
デクスクロルフェニラミン
d-クロロフェニラミン
4件:
HRH1
HRH1
,
NR3C1
,
PTGS1
,
PTGS2
💬
9.
Administration
of methylprednisolone, paracetamol and dexchlorpheniramine
×
Name
Full Name
HRH1
histamine receptor H1
NR3C1
nuclear receptor subfamily 3 group C member 1
PTGS1
prostaglandin-endoperoxide synthase 1
PTGS2
prostaglandin-endoperoxide synthase 2
26件:
Alzheimer disease
Alzheimer disease
,
Arachidonic acid metabolism
,
C-type lectin receptor signaling pathway
,
Calcium signaling pathway
,
Chemical carcinogenesis - DNA adducts
,
Human cytomegalovirus infection
,
Human papillomavirus infection
,
IL-17 signaling pathway
,
Inflammatory mediator regulation of TRP channels
,
Kaposi sarcoma-associated herpesvirus infection
,
Leishmaniasis
,
Metabolic pathways
,
MicroRNAs in cancer
,
NF-kappa B signaling pathway
,
Neuroactive ligand-receptor interaction
,
Ovarian steroidogenesis
,
Oxytocin signaling pathway
,
Pathways in cancer
,
Pathways of neurodegeneration - multiple diseases
,
Platelet activation
,
Regulation of lipolysis in adipocytes
,
Retrograde endocannabinoid signaling
,
Serotonergic synapse
,
Small cell lung cancer
,
TNF signaling pathway
,
VEGF signaling pathway
💬
26件:
Alzheimer disease
,
Arachidonic acid metabolism
,
C-type lectin receptor signaling pathway
,
Calci
...
1件:
49
49
💬
9.
Administration
of methylprednisolone, paracetamol and dexchlorpheniramine
×
告示番号
日本語名
英語名
49
全身性エリテマトーデス
Systemic lupus erythematosus
10
Administration
of rituximab and methylprednisolone
2件:
Methylprednisolone
Methylprednisolone
,
Rituximab
2件:
Methylprednisolone
Methylprednisolone
,
Rituximab
💬
10.
Administration
of rituximab and methylprednisolone
×
Name
Other Names
Methylprednisolone
Methylprednisolone (JP18/USP/INN)
Medrol (TN)
METHYLPRED DP
メチルプレドニゾロン
メドロール
Rituximab
Rituximab (USAN/INN)
Rituximab (genetical recombination) (JAN)
Rituximab (genetical recombination) [Rituximab biosimilar 1] (JAN)
Rituximab (genetical recombination) [Rituximab biosimilar 2] (JAN)
Rituximab-abbs
Rituximab-pvvr
Rituximab-arrx
Rituxan (TN)
Riabni (TN)
Truximab (TN)
RUXIENCE
TRUXIMA
リツキシマブ
リツキサン
リツキシマブBS
2件:
MS4A1
MS4A1
,
NR3C1
💬
10.
Administration
of rituximab and methylprednisolone
×
Name
Full Name
MS4A1
membrane spanning 4-domains A1
NR3C1
nuclear receptor subfamily 3 group C member 1
2件:
Hematopoietic cell lineage
Hematopoietic cell lineage
,
Neuroactive ligand-receptor interaction
💬
1件:
51
51
💬
10.
Administration
of rituximab and methylprednisolone
×
告示番号
日本語名
英語名
51
全身性強皮症
Scleroderma